article thumbnail

Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023

Lloyd Price

Executive Summary: The average multiples for digital therapeutics (DTx) M&A deals in 2023 are as follows: Enterprise value (EV) to sales: 5.6x Here are some additional insights into DTx M&A deals in 2023: The most active acquirers in the DTx M&A market are pharmaceutical companies, followed by technology companies.

article thumbnail

Kanabo Group Appoints Ian Mattioli as Chair of the Board and Secures a £2.5M Minimum Investment Round

Digital Health Global

In March 2023, Kanabo successfully launched its pain clinic, Treat It, under the expert guidance of its technological and product expertise. Treat It initially focuses on chronic pain management using plant-based medicine and treatments that are currently unavailable through traditional channels.

article thumbnail

Third Culture Capital Leads Latest Funding Round for Ciba Health

Digital Health Global

3CC Founder and Managing Partner Julien L. a chronic pain management and virtual care company, where he directed partnerships, clinical trials, regulatory submissions, hiring and expansion across North America. Ciba Health was recently named among NY Digital Health 100 winners for 2023.